Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypolipidemic imidazoles.

K H Baggaley, M Heald, R M Hindley

    Journal of Medicinal Chemistry
    |August 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    First Results on the Search for Lepton Number Violating Neutrinoless Double-β Decay with the LEGEND-200 Experiment.

    Physical review letters·2026
    Same author

    The impacts of compounding droughts: scaling from stomatal responses to ecosystem dynamics.

    Tree physiology·2025
    Same author

    The burden of skin and soft tissue, bone and joint infections in an Australian cohort of people who inject drugs.

    BMC infectious diseases·2024
    Same author

    Impact of changing from autopsy to post-mortem CT in an entire HM Coroner region due to a shortage of available pathologists.

    Clinical radiology·2023
    Same author

    Impact of the COVID-19 pandemic on a post-mortem CT service for adult non-suspicious death.

    Clinical radiology·2023
    Same author

    Prospects for beyond the Standard Model physics searches at the Deep Underground Neutrino Experiment: DUNE Collaboration.

    The European physical journal. C, Particles and fields·2021
    Same journal

    Development of Indole-3-yl-methylene-thiobarbital Derivatives as Inhibitors of HDAC8 Enzyme Activity.

    Journal of medicinal chemistry·2026
    Same journal

    Discovery of a Potent NAMPT-Targeting PROTAC for the Suppression of Triple-Negative Breast Cancer via Macrophage Reprogramming.

    Journal of medicinal chemistry·2026
    Same journal

    3',4'-Isopropylidene-α-galactosylceramide Enables Multidose Th1 Adjuvanticity Despite Limited Serial Serum IFN-γ Responsiveness.

    Journal of medicinal chemistry·2026
    Same journal

    A Bioorthogonally Cleavable <i>N</i>-Oxide Linker for Prodrug Design: Elucidating the Structure-Cyclization Kinetics Relationships for Controlled Drug Release.

    Journal of medicinal chemistry·2026
    Same journal

    A Melatonin-Catechol Hybrid Molecule Prolongs Lifespan via Regulating ROS and Reprogramming Mitochondrial Metabolism.

    Journal of medicinal chemistry·2026
    Same journal

    Discovery of SD-2301 as a Highly Potent and Selective PROTAC STAT3 Degrader Capable of Achieving Complete Tumor Regression with Single Administration.

    Journal of medicinal chemistry·2026
    See all related articles

    Researchers synthesized N-benzylimidazole analogs to assess their hypolipidemic effects. Several compounds demonstrated significant plasma cholesterol and triglyceride reduction, with specific methoxy and methyl derivatives showing the most promise.

    Area of Science:

    • Medicinal Chemistry
    • Pharmacology
    • Lipid Metabolism

    Background:

    • Hyperlipidemia, characterized by elevated plasma cholesterol and triglycerides, is a major risk factor for cardiovascular diseases.
    • Imidazole derivatives have shown potential in modulating lipid profiles.
    • Exploring novel chemical scaffolds is crucial for developing effective hypolipidemic agents.

    Purpose of the Study:

    • To synthesize and evaluate a series of N-benzylimidazole analogs for hypolipidemic activity.
    • To identify specific structural features responsible for cholesterol and triglyceride-lowering effects.
    • To establish structure-activity relationships (SAR) for this class of compounds.

    Main Methods:

    • Synthesis of various N-benzylimidazole analogs.

    Related Experiment Videos

  • In vivo or in vitro testing to determine plasma cholesterol and triglyceride levels.
  • Comparative analysis of compound efficacy based on structural modifications.

    • Main Results:

    • Several N-benzylimidazole analogs exhibited significant hypolipidemic activity.
    • Compounds N-3-methoxybenzylimidazole, N-4-methoxybenzylimidazole, and N-4-methylbenzylimidazole were identified as the most potent.
    • The study elucidated key structure-activity relationships influencing lipid-lowering efficacy.

    Conclusions:

    • N-benzylimidazole derivatives represent a promising class of compounds for managing hyperlipidemia.
    • Specific substitutions on the benzyl ring, such as methoxy and methyl groups, enhance hypolipidemic potency.
    • Further investigation into these analogs could lead to the development of novel therapeutic agents for dyslipidemia.